PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CliCon S.r.l. Health, Economics & Outcomes Research, Bologna, Italy.\', \'UOC Assistenza Farmaceutica Territoriale, Azienda ULSS 8 Berica, Vicenza, Italy.\', \'Dipartimento Farmaceutico, USL Umbria 2, Perugia, Italy.\', \'UOC Farmacia Aziendale, ASL, Viterbo, Italy.\', \'Dipartimento Farmaceutico, ASL, Foggia, Italy.\', \'UOC Farmaceutica Territoriale, ASL Roma 6, Rome, Italy.\', \'Dipartimento Tecnico-Amministrativo, ASL 3 Genovese, Genova, Italy.\', \'UOC Farmacia Territoriale, ASL Roma 4, Rome, Italy.\', \'Dipartimento Farmaceutico, ASL Naples 3 Sud, Naples, Italy.\', \'Rheumatology Unit, University of Verona, Verona, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/jbmr.4419
?:hasPublicationType
?:journal
  • Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
is ?:pmid of
?:pmid
?:pmid
  • 34405441
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34405441>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34405441>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all